0001493152-24-010572.txt : 20240319 0001493152-24-010572.hdr.sgml : 20240319 20240319214945 ACCESSION NUMBER: 0001493152-24-010572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240317 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLECKEL LOUIS MD CENTRAL INDEX KEY: 0001164762 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 24766185 MAIL ADDRESS: STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP STREET 2: 2800 METRUS AVE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0508 4 2024-03-17 0 0000868278 ProPhase Labs, Inc. PRPH 0001164762 GLECKEL LOUIS MD 711 STEWART AVENUE, SUITE 200 GARDEN CITY, NY 11530 1 0 0 0 0 Option (right to buy) 6.00 2024-03-17 4 A 0 70000 0 A 2031-03-17 Common Stock 70000 70000 D Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date. /s/ Louis Gleckel 2024-03-19